The Prothrombin-Prothrombinase Interaction
- 5 July 2024
- book chapter
- Published by Springer Nature
- Vol. 104, 409-423
Abstract
The hemostatic response to vascular injury entails a sequence of proteolytic events where several inactive zymogens of the trypsin family are converted to active proteases. The cascade starts with exposure of tissue factor from the damaged endothelium and culminates with conversion of prothrombin to thrombin in a reaction catalyzed by the prothrombinase complex composed of the enzyme factor Xa, cofactor Va, Ca2+, and phospholipids. This cofactor-dependent activation is paradigmatic of analogous reactions of the blood coagulation and complement cascades, which makes elucidation of its molecular mechanism of broad significance to the large class of trypsin-like zymogens to which prothrombin belongs. Because of its relevance as the most important reaction in the physiological response to vascular injury, as well as the main trigger of pathological thrombotic complications, the mechanism of prothrombin activation has been studied extensively. However, a molecular interpretation of this mechanism has become available only recently from important developments in structural biology. Here we review current knowledge on the prothrombin-prothrombinase interaction and outline future directions for the study of this key reaction of the coagulation cascade.Keywords
This publication has 98 references indexed in Scilit:
- Cryo‐EM structures of coagulation factorsResearch and Practice in Thrombosis and Haemostasis, 2022
- Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeuticsJournal of Thrombosis and Thrombolysis, 2021
- Single‐Particle Reconstruction of Biological Molecules—Story in a Sample (Nobel Lecture)Angewandte Chemie International Edition, 2018
- A model for the unique role of factor Va A2 domain extension in the human ternary thrombin-generating complexBiophysical Chemistry, 2015
- A revisit to the one form kinetic model of prothrombinaseBiophysical Chemistry, 2010
- Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577Bioorganic & Medicinal Chemistry Letters, 2009
- Na+ binding to meizothrombin desF1Cellular and Molecular Life Sciences, 2008
- Structure of Human Des(1-45) Factor Xa at 2·2 Å ResolutionJournal of Molecular Biology, 1993
- The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationshipsProtein Science, 1992
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991